MedTrace Logo

Randomized Control Trial for Overweight Employees in Worksites

NCT03249610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-08-15

No results posted yet for this study

Summary

Impact of lifestyle intervention in at-risk Asian Indians at worksite remains largely unexplored. The aim of this study was to assess impact of the multi-component interventions on body weight, body fat patterning and cardio-metabolic risk factors in overweight individuals working in corporate worksites in New Delhi, north India.

Conditions

  • Diabetes Mellitus, Type 2
  • Metabolic Syndrome
  • Lifestyle Risk Reduction

Interventions

BEHAVIORAL

Lifestyle intervention

Intervention Trial with Multi-Component Lifestyle Intervention for reduction of body weight and cardio-metabolic risk factors

Sponsors & Collaborators

  • Sprim Advanced Life Sciences

    collaborator OTHER

  • Abbott

    collaborator INDUSTRY

  • Diabetes Foundation, India

    lead OTHER

Principal Investigators

  • Dr. Anoop Misra · Diabetes Foundation, India

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-11
Primary Completion
2017-03-12
Completion
2017-06-15

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03249610 on ClinicalTrials.gov